Which core heterocycle is the defining feature of proton pump inhibitors?

Which core heterocycle is the defining feature of proton pump inhibitors?

• A. Carboxylic acid
• B. Ethanolamine
• C. Benzimidazole
• D. Ethylenediamine

Answer: (C)

PPIs share a benzimidazole-containing ring as their central scaffold. This benzimidazole core is what ties all the drugs in this class together and enables their activation in the acidic environment of the stomach. When activated in the parietal cell canaliculi, the molecule forms a reactive sulfenamide that irreversibly binds to and inhibits the H+/K+-ATPase (the proton pump), effectively reducing acid secretion. Other groups like carboxylic acid, ethanolamine, or ethylenediamine may be present in various drugs, but they do not define this drug class. The benzimidazole core is the defining feature because it underpins both the activation mechanism and the enzyme inhibition that characterizes proton pump inhibitors.

PPIs share a benzimidazole-containing ring as their central scaffold. This benzimidazole core is what ties all the drugs in this class together and enables their activation in the acidic environment of the stomach. When activated in the parietal cell canaliculi, the molecule forms a reactive sulfenamide that irreversibly binds to and inhibits the H+/K+-ATPase (the proton pump), effectively reducing acid secretion. Other groups like carboxylic acid, ethanolamine, or ethylenediamine may be present in various drugs, but they do not define this drug class. The benzimidazole core is the defining feature because it underpins both the activation mechanism and the enzyme inhibition that characterizes proton pump inhibitors.